Bli medlem
Bli medlem

Du är här


Inhalation Sciences: Inhalation Sciences receives new order worth 1.8 MSEK

Inhalation Sciences Sweden AB has received an order for a new
PreciseInhale system from an existing customer with global lab
facilities. The new order includes a range of exposure modules and
PreciseInhale's new customized nebulizer feature.

CEO Lena Heffler: "I'm pleased to see this trend of existing customers
returning to purchase a second instrument from ISAB. It speaks
volumes about the quality of data, range of capabilities and
important competitive edge PreciseInhale gives them".

ISAB's PreciseInhale aerosol generator generates accurate in vivo and
ex vivo data, from nebulized solutions as well as commercial dry
powder inhalers. The new purchase includes ISAB's new integrated
nebulizer feature, which the company launched in February 2019

CEO Lena Heffler: "This sale is a clear indication of the scientific
and strategic value PreciseInhale gives companies-enabling them to
generate more accurate data, minimize risk and accelerate research.
We're delighted with our customers' confidence in our technology's

or more information about Inhalation Sciences, please contact:

Lena Heffler, CEO
Telephone: +46 (0)70 205 9620

About Inhalations Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) develops and commercializes
world-leading instruments for research into inhalation. The company's
patented lab instrument, PreciseInhale®, enables researchers to
characterize, with high precision, how aerosols and small particles
impact our lungs, and so our health, when we inhale them.

The information above was provided by Inhalation Sciences AB according
to EU Market Abuse Regulations. The information was provided, through
the agency of the contact person above, for publication on August 23,


Författare Cision News

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.